Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Thierry Tarrade"'
Autor:
Monique Descroix-Vagne, Henri Benech, Fatima Abou El Fadil, Raymond Vienet, Danielle Pansu, Jean-Marc Grognet, Cathy Dumas, Thierry Tarrade, Gerard Jourdan, Philippe Nicol
Publikováno v:
Peptides. 16:1343-1350
The C-terminal heptapeptide-amide (C7-sorbin) is the minimal biologically active fragment of sorbin inducing an increase in intestinal hydroelectrolytic absorption. An analogue (D7-sorbin), characterized by the replacement of the ultimate C-terminal
Autor:
Matyas Koltai, Ildiko Jakab, Pierre Braquet, János Lonovics, Péter Ferdinandy, Zoltán Szilvássy, Michel Allard, Thierry Tarrade
Publikováno v:
Life Sciences. 54:PL125-PL130
Myocardial ischemia assessed by intracavital ST-segment elevation, shortening of ventricular effective refractory period (VERP), and increase in left ventricular end-diastolic pressure (LVEDP) was provoked by ventricular overdrive pacing (VOP) in con
Autor:
Fatima Abou El Fadil, Monique Descroix-Vagne, G. Charpin, Danielle Pansu, Cathy Dumas, Philippe Nicol, Thierry Tarrade, Gerard Jourdan, Jean Marc Grognet
Publikováno v:
Peptides. 15:1013-1019
Sorbin is a 153 amino acid peptide isolated from porcine small intestine. The heptapeptide-amide is the minimal active site of the natural molecule. A comparison of the distribution of C-7 and C-20 sorbin, which have been shown to share the activity
Autor:
Iidiko Jakab, Pierre Braquet, Andre Esanu, Thierry Tarrade, Matyas Koltai, Zoltán Szilvássy, Pal Bor, János Lonovics
Publikováno v:
Coronary Artery Disease. 4:443-452
Background This study examined whether cicletanine, an antihypertensive drug with cGMP phosphodiesterase inhibitory effect, could alleviate ventricular overdrive pacing-induced myocardial ischemia in chronically instrumented rabbits. Methods An elect
Autor:
Matyas Koltai, Péter Ferdinandy, Zoltán Szilvássy, Thierry Tarrade, Ildiko Jakab, János Lonovics, Pierre Braquet
Publikováno v:
Life Sciences. 53:PL13-PL18
In conscious rabbits equipped with right ventricular electrode and left ventricular polyethylene catheters, zaprinast and cicletanine, inhibitors of phosphodiesterase (PDE) V and PDEs I and V, respectively, as well as verapamil, a Ca2+ channel blocke
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 346:114-119
In contrast with cicletanine, its urinary sulfoconjugate metabolite (cicletanine sulfate) was active on membrane ion transport in human red blood cells. Cicletanine sulfate was a more potent inhibitor of the Na+ dependent [Cl-/HCO3-] exchanger (IC50
Publikováno v:
European Heart Journal. 13:395-403
We studied the effects of cicletanine, a furopyridine antihypertensive drug, and furosemide, a loop diuretic, on ventricular arrhythmias, such as sustained ventricular fibrillation (VF) and ventricular tachycardia (VT), and myocardial ion content in
Autor:
Marie-Antoinette Tran, Jean-Louis Montastruc, Jean-Loup Bascands, Christiane Pecher, Thierry Tarrade, Moatti Jp, Christine Damase-Michel, Jean-Pierre Girolami, P. Berthet
Publikováno v:
Fundamental & Clinical Pharmacology. 5:719-732
Summary— The present study investigates the antihypertensive action of cicletanine, a new antihypertensive compound with diuretic properties (or placebo), on vasopressor (catecholamines, renin-aldosterone) as well as vasodepressor (prostaglandins,
Autor:
Péter Ferdinandy, Marie Therese Droy-Lefaix, Thierry Tarrade, Matyas Koltai, Zoltán Szilvássy
Publikováno v:
Cardiovascular research. 30(5)
Objectives: We studied the effects of ATP-sensitive potassium channel (KATP) modulation on ischemic cardiac performance and reperfusion-induced ventricular fibrillation (VF), and assessed the contribution of KATP to the cardioprotective and anti-arrh
Autor:
Joel Rakotoarivony, Jean-Pierre Girolami, Guy Bompart, C. Emond, P. Berthet, Christiane Pecher, Jean-Loup Bascands, Thierry Tarrade, Albert Adam
Publikováno v:
Journal of cardiovascular pharmacology. 20(4)
We investigated the effect of two oral (p.o.) doses of cicletanine (5 and 30 mg/kg/day) for 4 weeks on urinary excretion (UKE), renal concentration (RKC) of kallikrein, and prostaglandin E2 (PGE2) and 6-keto-PGF1 alpha urinary excretion of stroke-pro